Vineet Laboratories Share Price

NSE: VINEETLAB

S Cap

₹ 38.00

-₹0.44 (-1.14%)

Last updated 14 Aug, 2026, 09:55 IST

Vineet Laboratories Share Price Today

As of 14 Aug 2026, Vineet Laboratories share price is ₹38.00. The stock opened at ₹40.00, compared to its previous close of ₹38.44. During today's trading session, Vineet Laboratories share price moved in the range of ₹37.62 to ₹40.00, with an average price of ₹38.81 for the day. Looking at its last 52-week, the stock has touched a low of ₹26.89 and a high of ₹43.50. On the performance front, Vineet Laboratories share price has increased by 24.93% over the last six months and is up 11.65% on a year-on-year basis.

₹37.62

1.14% down today

₹40.00

1D LOW

1D HIGH

Stock Performance

OutperformingBeat Nifty by 14.43 % in last 1 month

Shareholding Pattern

FIIFII increased stake by 38.55%

Vineet Laboratories Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹5,51,844+₹51,844 (+10.37%)

3 Year

₹3,68,574-₹1,31,426 (-26.29%)

5 Year

₹2,23,267-₹2,76,733 (-55.35%)

₹36.52₹40.36

Circuit Low

Circuit High

₹26.89₹43.50

52-Week Low

52-Week High

Circuit

₹36.52

₹40.36

52-week

₹26.89

₹43.50

About Vineet Laboratories

ISIN

INE505Y01010

Sector Market Cap

₹ 74.9 Cr

Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.

Vineet Laboratories Financial Highlights

Revenue: Vineet Laboratories reported revenue of ₹76.99 crore in FY25 vs ₹151.05 crore in FY24. It showed a decrease of 49.03% on a yearly basis.
Operating Profit: Vineet Laboratories reported an operating loss of ₹20.78 crore in FY25 vs ₹0.36 crore in FY24. It showed a decrease of 5,872.22% on a year-on-year basis.
Net Profit: Vineet Laboratories reported a net loss of ₹20.19 crore in FY25 vs ₹1.03 crore in FY24. It showed a decrease of 2,060.19% on a yearly basis.

Vineet Laboratories Quarterly Result Highlights

Vineet Laboratories reported revenue of ₹15.70 crore in Dec 2025, compared with ₹17.43 crore in Sep 2025, representing a decrease of 9.93% on a quarter-on-quarter (QoQ) basis.
Vineet Laboratories reported an operating profit of ₹0.82 crore in Dec 2025, compared with ₹0.37 crore in Sep 2025, representing an increase of 121.62% on a quarter-on-quarter (QoQ) basis.
Vineet Laboratories reported a profit of ₹0.85 crore in Dec 2025, compared with ₹0.40 crore in Sep 2025, reflecting an increase of 112.50% on a QoQ basis.
The earnings per share (EPS) of Vineet Laboratories stood at ₹21.90 during Dec 2025.

Know more

Promoters

5.98%

FII

0.50%

Other DII

0.00%

Retail and other

93.52%

Mutual funds

0.00%

Foreign institutions - FII

FII shareholding by period
Dec 2025	0.00%
Feb 2026	0.00%
Mar 2026	0.36%
Jun 2026	0.50%

Mkt Cap Cr

74.90

P/E

-7.27

P/B

1.67

ROE

-117.41%

D/E

3.01

ROCE

-22.41%

Div. Yield

0.00%

EPS(TTM)

-21.90

Turnover

0.60

EV/EBITDA

-32.50

Net Margin

-26.92%

Op. Margin

-19.05%

ROA

-11.20%

Quick Ratio

0.23

Curr. Ratio

2.05

Mkt Cap Cr

74.90

P/E

-7.27

P/B

1.67

ROE

-117.41%

D/E

3.01

ROCE

-22.41%

Div. Yield

0.00%

EPS(TTM)

-21.90

Turnover

0.60

EV/EBITDA

-32.50

Net Margin

-26.92%

Op. Margin

-19.05%

ROA

-11.20%

Quick Ratio

0.23

Curr. Ratio

2.05

Based on fundamentals, this stock's

Performance

Excellent

Vineet Laborator outperforming all market indices

Valuation

Overvalued

Vineet Laborator appears overvalued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,66,155.00	38.47	5.58	13.74%	0.61	17.33%	93.24	0.83%	0.48	10.90
Divis Laboratories	2,26,843.00	77.15	13.46	15.32%	0.00	19.56%	629.49	0.35%	0.55	98.19
Torrent Pharmaceuticals	1,86,000.00	86.27	22.12	25.49%	1.69	13.85%	222.76	0.69%	0.49	58.70
Zydus Lifesciences	1,17,007.00	26.15	4.43	18.59%	0.31	17.35%	237.30	0.08%	0.33	35.38
Cipla	1,18,027.00	35.17	3.43	11.27%	0.00	14.95%	423.36	0.89%	0.45	43.52
Lupin	1,03,549.00	18.62	4.61	23.76%	0.04	24.88%	659.05	0.79%	0.57	129.18
Mankind Pharma	1,00,137.00	48.43	6.14	11.74%	0.34	13.13%	397.02	0.04%	0.44	49.37
Dr. Reddy's Laboratories	1,00,662.00	31.62	2.64	11.07%	0.18	12.54%	377.96	0.67%	0.41	38.68
Laurus Labs	99,474.20	91.23	18.77	16.77%	0.40	16.14%	97.20	0.11%	0.67	13.72
Aurobindo Pharma	96,215.60	26.06	2.55	9.25%	0.19	11.76%	391.14	0.24%	0.38	41.58

Vineet Laboratories Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹75.00	₹150.59	₹212.29	₹191.17
Other Income	₹1.99	₹0.46	₹0.12	₹0.29
Total Revenue	₹76.98	₹151.05	₹212.42	₹191.46
Total Expenses	₹97.76	₹150.69	₹210.39	₹182.11
Profit Before Tax	-₹20.78	₹0.36	₹2.03	₹9.35
Tax	-₹0.58	-₹0.66	₹0.78	₹2.71
Profit After Tax	-₹20.19	₹1.03	₹1.25	₹6.64
EPS - Basic	-₹21.90	₹1.11	₹1.36	₹7.16
EPS - Diluted	-₹21.90	₹1.11	₹1.36	₹7.16

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	-₹20.78	₹0.36	₹2.03	₹9.35
Income before WC changes	-₹12.34	₹7.15	₹8.00	₹13.25
Change in Assets	₹21.13	-₹1.21	₹5.87	-₹7.16
Change in Liabilities	₹2.82	-₹12.29	-₹20.50	₹4.72
Change in WC	₹23.95	-₹13.50	-₹14.63	-₹2.43
Cash flow from Operations	₹11.49	-₹6.61	-₹9.62	₹7.63
Cash flow from Investing	-₹3.18	-₹2.22	-₹6.69	-₹3.68
Cash flow from Financing	-₹8.23	₹8.43	₹0.27	₹11.96
Total Cash Flow	₹0.08	-₹0.40	-₹16.03	₹15.91
Cash (Start of the year)	₹0.23	₹0.63	₹16.66	₹0.75
Cash (End of the year)	₹0.31	₹0.23	₹0.63	₹16.66

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹27.15	₹28.68	₹28.39	₹30.61
Current Assets	₹67.39	₹88.19	₹87.46	₹102.70
Total Assets	₹94.54	₹116.87	₹115.85	₹133.32
Current Liabilities	₹74.39	₹76.00	₹74.51	₹94.77
Net Current Asset	-₹7.00	₹12.19	₹12.95	₹7.94
Non-Current Liabilities	₹5.50	₹6.15	₹7.66	₹5.33
Equity Capital	₹14.65	₹34.72	₹33.68	₹33.22
Total Equity & Liabilities	₹94.54	₹116.87	₹115.85	₹133.32